Ex vivo gene transfer in the years to come

Arthritis Research

Volumn 4, Issue 1, 2002, Pages 10-12

  Pap, Thomas ^a,b   Gay, Renate E ^b   Müller Ladner, Ulf ^c   Gay, Steffen ^b  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Ex vivo approach; Gene therapy; Rheumatoid arthritis; Viral vector

Indexed keywords

CELL SURFACE RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; VIRUS VECTOR;

ARTICLE; CELL PROLIFERATION; CLINICAL PROTOCOL; CLINICAL STUDY; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; GENE TRANSFER; GENETIC HETEROGENEITY; GENETIC TRANSDUCTION; HUMAN; RETROVIRUS; RHEUMATOID ARTHRITIS; SYNOVIUM; TARGET CELL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ARTHRITIS, RHEUMATOID; FIBROBLASTS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; SYNOVIAL MEMBRANE;

EID: 0036153897     PISSN: 14659905     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar377     Document Type: Article

References (24)

1. Gene transfer: From concept to therapy
2. Gene therapy in rheumatoid arthritis: How to target joint destruction?
3. Intraarticular expression of biologically active interleukin 1-receptor- antagonist protein by ex vivo gene transfer
4. Gene therapy of arthritis
5. Gene therapy of rheumatoid arthritis via cytokine regulation: Future perspectives
6. Anticytokine therapy in rheumatoid arthritis
7. TNF blockade in rheumatoid arthritis: Implications for therapy and pathogenesis
8. Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model
9. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis
10. Activation of synoviocytes
11. Improved methods of retroviral vector transduction and production for gene therapy
12. Optimization of gene transfer into intestinal epithelial cells using a retroviral vector
13. Enhanced in vitro and in vivo gene delivery using cationic agent complexed retrovirus vectors
14. Centrifugal enhancement of retroviral mediated gene transfer
15. Consistent and high rates of gene transfer can be obtained using flow- through transduction over a wide range of retroviral titers
16. Approaches to enhancing the retroviral transduction of human synoviocytes
17. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis
18. Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective
19. Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion
20. Gene therapy moves forward - The second international meeting on gene and cell therapies of arthritis and related disorders, 17-18 May 2001, Montpellier, France
21. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis
22. Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta
23. Myoblast-mediated gene transfer to the joint
24. Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis